That line is increasingly blurred with the potential for a fundamental impact on global growth – the new US administration’s ...

Migration is such a hot button issue, yet its true dimensions are obscured by political rhetoric that whips up hysteria.

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

The current wave of anti-immigration campaign in Russia, as the research center Sova noticed, began back in the fall of 2021, ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

It’s tiny, it’s silver and it’s at the center of a decades-long controversy over California’s water system. It’s the delta ...

After revolutionising vegan cheese, Miyoko Schinner is leveraging her decades-long experience to lead a plant-based course at ...

The early ‘70s ushered in a phenomenon called "population doomerism." In 1968, biologist Paul Erlich published "The ...

We do so forgetting our own contribution to underdevelopment and poverty trap. According to Synthesis Report on the ...

New research from Sage Growth Partners notes that “a more substantive transition to value-based care” could be coming — but it has competition.

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...